WASHINGTON (Reuters) - Two studies published on Thursday offer new hope for Parkinson’s disease -- one using gene therapy to treat the symptoms and another investigating a drug that might stop the incurable disease in its tracks.While both are in early experimental stages, each takes a new approach to treating the devastating brain condition, which affects millions of people globally.
